Accessibility Menu

Franklin Strategic Series - Franklin Biotechnology Discovery Fund(NASDAQMUTFUND) FBDIX

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)+2,226%
5 Year+76%
1 Year+68%
1 Month+5%
$202.48
-3.12%
-6.52Today
Franklin Strategic Series - Franklin Biotechnology Discovery Fund last closing stock price
MetricPriceDate
Last closeUSD 202.482026-08-28
Franklin Strategic Series - Franklin Biotechnology Discovery Fund stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.64%USD 210.122026-08-21
1 month+4.66%USD 193.472026-07-29
3 month+13.24%USD 178.802026-05-29
Year to date+22.17%USD 165.742025-12-31
1 year+68.12%USD 120.442025-08-28
3 year+118.28%USD 92.762023-08-29
5 year+76.27%USD 114.872021-08-27
Since inception+2,225.55%USD 8.711997-12-12

Franklin Strategic Series - Franklin Biotechnology Discovery Fund Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$202.48

Volume

N/A

Open

$209.00

Previous Close

$202.48

Daily Range

$202.48 - $202.48

52-Week Range

$202.48 - $202.48

Estimated Earnings Date

N/A

FBDIX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

FBDIX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

N/A

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About FBDIX

What is the current price of Franklin Strategic Series - Franklin Biotechnology Discovery Fund?

Franklin Strategic Series - Franklin Biotechnology Discovery Fund is trading at $202.48 per share.

What is the 52-week range for Franklin Strategic Series - Franklin Biotechnology Discovery Fund?

Over the past 52 weeks, Franklin Strategic Series - Franklin Biotechnology Discovery Fund has traded between $202.48 and $202.48.

How much debt does Franklin Strategic Series - Franklin Biotechnology Discovery Fund have?

Franklin Strategic Series - Franklin Biotechnology Discovery Fund total debt is unavailable.

How much cash does Franklin Strategic Series - Franklin Biotechnology Discovery Fund have on hand?

Franklin Strategic Series - Franklin Biotechnology Discovery Fund does not have cash on hand data available.

What is Franklin Strategic Series - Franklin Biotechnology Discovery Fund’s dividend yield?

Franklin Strategic Series - Franklin Biotechnology Discovery Fund does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.